Лучшие больницы для «Limb Lengthening Surgery» в Дубай, ОАЭ

The total cost of limb lengthening surgery in India ranges from approximately USD 5,000 to USD 14,000, depending on the technique selected (PRECICE motorized internal nail, Taylor Spatial Frame, Ilizarov external fixator, or hybrid LON), the number of bones treated, and the hospital tier. This typically includes the surgeon's fee, hospital stay of 5–10 days, anesthesia, implant cost, intraoperative fluoroscopy, standard physiotherapy during admission, and standard medications. In the UAE (Dubai or Abu Dhabi), the equivalent procedure at a JCI-accredited hospital costs between approximately USD 13,000 and USD 35,000, reflecting premium hospital infrastructure, higher operational costs, and specialist consultation fees. India therefore offers savings of 50–65% for comparable quality, with many Indian centers holding both JCI and NABH accreditation and surgeons trained at institutes such as AIIMS, Bombay, or internationally at Paley Orthopedic & Spine Institute. Implant cost is a significant variable: the PRECICE 2 or PRECICE STRYDE nail alone costs USD 6,000–10,000 at wholesale, and this is often the single largest cost driver regardless of destination. GAF Healthcare provides a fully itemized, no-hidden-cost quote for both destinations upon review of your medical records, allowing you to make a direct, like-for-like comparison.

This is one of the most critical planning considerations for international patients, and the answer depends on the surgical technique used and your individual clinical progress. As a general framework: for patients undergoing PRECICE internal nail lengthening, the minimum recommended country-stay before short-haul flights (under 3 hours) is 6–8 weeks. For long-haul flights exceeding 6 hours, the recommendation extends to 10–14 weeks, by which point the active distraction phase is typically complete or near-complete, and early consolidation has been radiographically confirmed. For patients with external fixators (TSF, Ilizarov), travel is possible while the frame is in situ, but requires careful logistics: the frame adds bulk, airports and airline staff must be briefed, and security screening requires a medical device declaration letter, which GAF Healthcare prepares in advance. These patients can often travel at 6–10 weeks if their pin-site care is well-established and a local physiotherapist has been identified in their home country. The critical milestones that determine fit-to-fly status are: wound healing, resolution of acute post-operative pain manageable on oral analgesia, patient and family competence in device management (ERC or strut adjustment), initiation of stable partial weight-bearing, and first outpatient radiograph at 10–14 days confirming satisfactory hardware position and early callus. Deep vein thrombosis (DVT) prophylaxis with low molecular weight heparin (e.g., enoxaparin) is mandatory for any long-haul flight during the active treatment period, and compression stockings on the unaffected limb are strongly advised. Your treating surgeon at the GAF Healthcare partner hospital will provide a formal fit-to-fly certificate specifying any flight restrictions, compression requirements, and emergency contact protocols for the aviation medical team.

Limb lengthening surgery achieves a bone-healing (consolidation) success rate of 85–95% at high-volume specialist centers, with outcomes graded using validated systems such as the ASAMI (Association for the Study and Application of the Method of Ilizarov) scoring system, which evaluates both bone results (union, infection, deformity, length) and functional results (active movement, pain, soft tissue status, gait). Bone results are rated as Excellent (union with no deformity, infection, or failure), Good, Fair, or Poor. Functional results incorporate joint range of motion, pain, and return to daily activities. In the modern era of motorized internal nails (PRECICE system), reported excellent/good ASAMI bone results range from 88–96% in published series from centers in the United States, South Korea, and Europe, with patient satisfaction rates consistently exceeding 90% in elective cosmetic lengthening cohorts. For congenital conditions such as achondroplasia or fibular hemimelia, success rates are similarly high when patients undergo treatment at the appropriate developmental stage under an experienced pediatric limb reconstruction surgeon. The most important predictors of success are: surgeon experience (annual case volume > 50 limb reconstructions is the benchmark for high-volume centers), patient compliance with the distraction schedule and daily physiotherapy, adequate nutritional and bone metabolic status pre-operatively (Vitamin D3 sufficiency, protein adequacy), and the absence of active infection. Failure modes — including non-union, premature consolidation, axial deviation, and joint contracture — are typically manageable with protocol adjustments and do not usually result in permanent disability when identified early through diligent monitoring. GAF Healthcare exclusively partners with orthopedic units where the lead surgeon's published outcomes and complication rates are transparently available for patient review.